The prominent players in travel vaccines market are
GSK plc
Sanofi
Janssen Pharmaceuticals Inc.
Pfizer Inc.
CSL Ltd.
Qiagen N.V.
AstraZeneca
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Valneva Inc.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market size for travel vaccines was worth USD 3.8 billion in 2022 and will record 9.7% CAGR from 2023 to 2032 due to the surging awareness about vaccine-preventable diseases among travellers.
Mono travel vaccines market size is expected to witness 9.2% CAGR from 2023-2032 owing to the surging need to provide targeted protection against specific diseases.
The outbound travel application segment is expected to witness 9.1% CAGR from 2023-2032 owing to increasing travel for different purposes such as business, vacations, medical tourism, migration, and other purposes.
North America travel vaccines industry size was USD 1.6 billion in 2022 and may reach USD 4 billion by 2032 due to significant number of outbound and domestic trips